<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75">
 <label>75.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guy</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Barrere</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Malinowski</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Saville</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Teyssou</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>J</given-names>
   </name>
  </person-group>. 
  <article-title>From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine</article-title>. 
  <source>Vaccine.</source> (
  <year>2011</year>) 
  <volume>29</volume>:
  <fpage>7229</fpage>â€“
  <lpage>41</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.06.094</pub-id>
  <?supplied-pmid 21745521?>
  <pub-id pub-id-type="pmid">21745521</pub-id>
 </mixed-citation>
</ref>
